About This Fund
The fund, SK Capital Partners VI, focuses on transformative investments in the specialty materials, ingredients, and life sciences industries. The fund exceeded its target at $2.95 billion, showcasing the strong support from investors for the Firm’s private investment strategy. SK Capital is well-capitalized and well-positioned to provide capital solutions to entrepreneurs, families, and corporates across all transaction sizes through a unique style of transformative control investing. The fund aims to partner with diverse and experienced private equity investors, deepening relationships with long-standing partners and diversifying the investor base globally. SK Capital seeks to build resilient, sustainable, and growing businesses that create substantial long-term value in the sectors it invests in. With a portfolio of businesses generating revenues of approximately $14 billion annually, employing more than 25,000 people globally, and operating in over 30 countries, SK Capital has approximately $7.9 billion in assets under management. The firm aims to utilize its industry, operating, and investment experience to transform businesses into higher performing organizations with improved strategic positioning, growth, profitability, and lower operating risk.